Mitchell Shirvan

VP Innovation & Discovery, Foamix Pharmaceuticals Ltd.

Companies

Silexion Therapeutics CorpCSO and DO Aug 15, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silexion Therapeutics Corp SLXN8,789 shares²$1.3K at $0.14Jun 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 4, 2026Granted 6,000 shares of Silexion Therapeutics Corp²
Mar 26, 2026Sold 22,818 shares at $1.36 of Silexion Therapeutics Corp³
Feb 20, 2026Granted 49,726 shares of Silexion Therapeutics Corp⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSilexion Therapeutics Corp, CSO and DO
2
SEC EDGARSilexion Therapeutics Corp shares after the filing of Jun 4, 2026
3
SEC EDGARForm 4 filed Mar 30, 2026
4
SEC EDGARForm 4 filed Feb 23, 2026